Clinical and prognostic impact of <i>STAG2</i> mutations in myeloid neoplasms: the Mayo Clinic experience-Reference-Cited by-同舟云学术

Clinical and prognostic impact of STAG2 mutations in myeloid neoplasms: the Mayo Clinic experience

Published:2023-04-12 Issue:8 Volume:7 Page:1351-1355
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Katamesh Bahga¹^ORCID,Nanaa Ahmad¹²^ORCID,He Rong³^ORCID,Viswanatha David³,Nguyen Phuong³,Greipp Patricia³^ORCID,Bessonen Kurt⁴,Gangat Naseema¹^ORCID,Begna Kebede¹^ORCID,Mangaonkar Abhishek¹,Patnaik Mrinal¹^ORCID,Hogan William J.¹,Tefferi Ayalew¹,Litzow Mark¹^ORCID,Shah Mithun Vinod¹^ORCID,Yi Cecilia Arana⁵^ORCID,Foran James⁶,Badar Talha⁶^ORCID,Alkhateeb Hassan B.¹,Al-Kali Aref¹^ORCID

Affiliation:

1. 1Division of Hematology, Mayo Clinic, Rochester, MN

2. 2John H. Stroger, Jr. Hospital of Cook County, Chicago, IL

3. 3Division of Hematopathology, Mayo Clinic, Rochester, MN

4. 4Division of Molecular Hematology, Mayo Clinic, Rochester, MN

5. 5Division of Hematology, Mayo Clinic, Scottsdale, AZ

6. 6Division of Hematology, Mayo Clinic, Jacksonville, FL

Publisher

American Society of Hematology

Subject

Hematology

Link